Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Import duties on four Marion Merrell Dow drugs

Executive Summary

Would be suspended through calendar year 1992, under legislation introduced Feb. 21 by Rep. Gradison (R-Ohio) and Feb. 5 by Senate Minority Leader Dole (R-Kan.). The products affected are Carafate (sucralfate), licensed from Japan's Chugai; Pentasa (masalamine) licensed from the Danish firm Ferring A.S., and Cardizem (diltiazem) and Cardizem-analog TA 3090, both licensed from Tanabe. Neither the House Ways & Means Committee nor the Senate Finance Committee has scheduled hearings on HR 4017, 4020-4022 or S2060-2063. In a Senate floor statement, Dole described the duty suspensions as "entirely noncontroversial".
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel